Code Snippets
curl "https://financialdata.net/api/v1/analyst-consensus?identifier=SYK&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/analyst-consensus?identifier=SYK&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/analyst-consensus?identifier=SYK&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "SYK",
"central_index_key": "0000310764",
"registrant_name": "STRYKER CORP",
"average_price_target": 364.72,
"highest_price_target": 420.0,
"lowest_price_target": 298.0,
"buy_recommendations": 18,
"sell_recommendations": 0,
"hold_recommendations": 2
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Analyst consensus represents the collective price targets and ratings from professional equity research analysts covering a publicly traded company. Aggregating the estimates gives a view of overall sentiment rather than relying on a single opinion. The API endpoint returns consensus metrics, including 12-month forward price targets as well as buy, hold, and sell recommendation counts.
Company Profile
STRYKER CORP
NYSE: SYK- Market Cap:$144.31B
- ISIN:US8636671013
- Fiscal Year End:12/31
- CEO:Kevin A. Lobo
- Employees:53000
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.